China Pharma Holdings (CPHI) Notes Payables (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Notes Payables came in at $1.5 million in Q1 2026, up 27.12% YoY from $1.2 million in Q1 2025, and up 2.16% on a QoQ basis from $1.4 million in Q4 2025.
China Pharma Holdings (CPHI) Notes Payables (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 12 years of Notes Payables data on file, last reported at $1.5 million in Q1 2026.
- Quarterly Notes Payables rose 27.12% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 27.12% YoY) and the FY2025 annual result came in at $1.4 million, up 25.34% from the prior year.
- Notes Payables rose to $1.5 million in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $4.6 million in Q3 2022 to a low of $315428.0 in Q3 2024.
- A 5-year average of $1.7 million and a median of $1.4 million in 2025 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2024 — Notes Payables plunged 84.44% — and 2025, when it surged 348.07%.
- Tracing CPHI's Notes Payables over 5 years: stood at $3.8 million in 2022, then tumbled by 70.16% to $1.1 million in 2023, then grew by 0.99% to $1.1 million in 2024, then increased by 25.34% to $1.4 million in 2025, then rose by 2.16% to $1.5 million in 2026.
- The last three Notes Payables figures came in at $1.5 million (Q1 2026), $1.4 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.47 Mn |
| Dec 31, 2025 | 1.44 Mn |
| Sep 30, 2025 | 1.41 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 315,428.00 |
| Jun 30, 2024 | 410,415.00 |
| Mar 31, 2024 | 490,000.00 |
| Dec 31, 2023 | 1.13 Mn |
| Sep 30, 2023 | 1.74 Mn |
| Jun 30, 2023 | 2.35 Mn |
| Mar 31, 2023 | 3.15 Mn |
| Dec 31, 2022 | 3.80 Mn |
| Sep 30, 2022 | 4.55 Mn |
| Sep 30, 2016 | 2.25 Mn |
| Jun 30, 2016 | 4.52 Mn |
| Mar 31, 2016 | 4.65 Mn |
| Dec 31, 2015 | 4.62 Mn |
| Sep 30, 2015 | 4.72 Mn |